Christophe Nougier

831 total citations
44 papers, 560 citations indexed

About

Christophe Nougier is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Christophe Nougier has authored 44 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 10 papers in Genetics and 8 papers in Physiology. Recurrent topics in Christophe Nougier's work include Hemophilia Treatment and Research (21 papers), Blood Coagulation and Thrombosis Mechanisms (14 papers) and Platelet Disorders and Treatments (10 papers). Christophe Nougier is often cited by papers focused on Hemophilia Treatment and Research (21 papers), Blood Coagulation and Thrombosis Mechanisms (14 papers) and Platelet Disorders and Treatments (10 papers). Christophe Nougier collaborates with scholars based in France, United States and Austria. Christophe Nougier's co-authors include Claude Négrier, Yesim Dargaud, H. Desmurs‐Clavel, Marie Simon, Laurent Argaud, Jean David, A. Bonnet, Guillaume Marcotte, Christine Vinciguerra and Anne Lienhart and has published in prestigious journals such as Blood, Scientific Reports and Intensive Care Medicine.

In The Last Decade

Christophe Nougier

33 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Nougier France 11 203 195 88 88 76 44 560
C. Belizna France 10 133 0.7× 100 0.5× 47 0.5× 99 1.1× 56 0.7× 26 470
Helen Enright Ireland 14 76 0.4× 345 1.8× 81 0.9× 22 0.3× 44 0.6× 41 625
Tariq Kewan United States 11 170 0.8× 108 0.6× 58 0.7× 117 1.3× 39 0.5× 70 407
Fien A. von Meijenfeldt Netherlands 13 430 2.1× 56 0.3× 182 2.1× 212 2.4× 73 1.0× 17 863
Inga Hegemann Switzerland 13 71 0.3× 241 1.2× 39 0.4× 32 0.4× 23 0.3× 26 510
Cristhiam M. Rojas‐Hernandez United States 14 103 0.5× 228 1.2× 41 0.5× 28 0.3× 26 0.3× 61 551
Dario Bongiovanni Germany 11 77 0.4× 92 0.5× 135 1.5× 24 0.3× 60 0.8× 47 573
Hugues Jacqmin Belgium 8 57 0.3× 106 0.5× 22 0.3× 20 0.2× 61 0.8× 20 363
Hisao Hara Japan 14 50 0.2× 76 0.4× 65 0.7× 38 0.4× 139 1.8× 84 780
Tiffany Pascreau France 10 74 0.4× 74 0.4× 75 0.9× 15 0.2× 75 1.0× 25 347

Countries citing papers authored by Christophe Nougier

Since Specialization
Citations

This map shows the geographic impact of Christophe Nougier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Nougier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Nougier more than expected).

Fields of papers citing papers by Christophe Nougier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Nougier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Nougier. The network helps show where Christophe Nougier may publish in the future.

Co-authorship network of co-authors of Christophe Nougier

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Nougier. A scholar is included among the top collaborators of Christophe Nougier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Nougier. Christophe Nougier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nougier, Christophe, et al.. (2025). In vitro combined haemostatic efficacy of emicizumab and extended half‐life factor VIII compounds. Haemophilia. 31(2). 224–230.
2.
Mourey, Guillaume, Valérie Eschwège, Dominique Lasne, et al.. (2025). Drug‐Specific Calibration: A Solution to Reagent Variability in Extended Half‐Life Factor IX Activity Measurements. Haemophilia. 31(6). 1307–1314.
3.
Dargaud, Yesim, et al.. (2025). Current trends and advances in the management of acquired Hemophilia A. Blood Reviews. 74. 101320–101320.
4.
Balsat, Marie, Hélène Labussière‐Wallet, Vincent Alcazer, et al.. (2025). Thrombocytosis drives alteration of primary hemostasis and acquired von willebrand syndrome occurrence in myeloproliferative neoplasms. Blood. 146(Supplement 1). 5570–5570.
5.
Catella, Judith, E Turpin, Philippe Connes, et al.. (2024). Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healing. British Journal of Haematology. 205(6). 2459–2469.
6.
Hanss, Michel, et al.. (2024). In vitro effect of hydroxyethyl starch on COVID-19 patients–associated hypofibrinolytic state. Research and Practice in Thrombosis and Haemostasis. 8(2). 102382–102382. 1 indexed citations
7.
Nourredine, Mikaïl, Stanislas Ledochowski, Frédéric Dailler, et al.. (2024). Trajectory of mean platelet volume changes after aneurysmal subarachnoid hemorrhage in patients with or without delayed cerebral ischemia. Scientific Reports. 14(1). 25122–25122.
8.
Moreuil, Claire de, Yesim Dargaud, Christophe Nougier, et al.. (2023). Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery. Journal of Thrombosis and Haemostasis. 21(11). 3099–3108. 3 indexed citations
9.
10.
Dargaud, Yesim, Sandrine Meunier, Sandra Le Quellec, et al.. (2022). Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: A retrospective single‐centre study. Haemophilia. 28(2). 301–307. 5 indexed citations
11.
Nougier, Christophe, et al.. (2021). The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapy. International Journal of Laboratory Hematology. 44(2). 371–378. 4 indexed citations
12.
Nougier, Christophe, Emmanuelle Jeanpierre, Catherine Ternisien, et al.. (2020). Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals). European Journal Of Haematology. 105(6). 675–681. 17 indexed citations
13.
Nougier, Christophe, Marie Simon, H. Desmurs‐Clavel, et al.. (2020). Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis. Journal of Thrombosis and Haemostasis. 18(9). 2215–2219. 207 indexed citations
14.
Nougier, Christophe, et al.. (2020). Prospective evaluation of two specific IgG immunoassays (HemosIL® AcuStar HIT‐IgG and HAT45G®) for the diagnosis of heparin‐induced thrombocytopenia: A Bayesian approach. International Journal of Laboratory Hematology. 43(3). 468–476. 2 indexed citations
15.
Jeanpierre, Emmanuelle, Claire Pouplard, Dominique Lasne, et al.. (2020). Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT). European Journal Of Haematology. 105(2). 103–115. 9 indexed citations
16.
Nougier, Christophe, et al.. (2019). Effects of hemolysis, bilirubin, and lipemia interference on coagulation tests detected by two analytical systems. International Journal of Laboratory Hematology. 42(1). 88–94. 15 indexed citations
17.
Lasne, Dominique, Claire Pouplard, Christophe Nougier, et al.. (2019). Factor VIII assays in treated hemophilia A patients. Annales de biologie clinique. 77(1). 53–65.
18.
Quellec, Sandra Le, Christophe Nougier, Lucia Rugeri, et al.. (2016). Pre-analytical effects of pneumatic tube system transport on routine haematology and coagulation tests, global coagulation assays and platelet function assays. Thrombosis Research. 153. 7–13. 28 indexed citations
19.
Lienhart, Anne, et al.. (2008). Determining the adequate number of internal quality control levels: the example of coagulation factor VIII assay. Blood Coagulation & Fibrinolysis. 19(5). 433–437. 6 indexed citations
20.
Vinciguerra, Christine, Christophe Zawadzki, Yesim Dargaud, et al.. (2006). Characterisation of 96 mutations in 128 unrelated severe haemophilia A patients from France. Thrombosis and Haemostasis. 95(4). 593–599. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Belizna Breakdown of academic impact, for papers by Helen Enright Breakdown of academic impact, for papers by Tariq Kewan Breakdown of academic impact, for papers by Fien A. von Meijenfeldt Breakdown of academic impact, for papers by Inga Hegemann Breakdown of academic impact, for papers by Cristhiam M. Rojas‐Hernandez Breakdown of academic impact, for papers by Dario Bongiovanni Breakdown of academic impact, for papers by Hugues Jacqmin Breakdown of academic impact, for papers by Hisao Hara Breakdown of academic impact, for papers by Tiffany Pascreau
Rankless by CCL
2026